Rodman & Renshaw Initiates Coverage on Alphatec Holdings (ATEC) with a Market Perform
More News related to ATEC
- Alphatec Spine to Present At Rodman & Renshaw and Lazard Capital Markets Healthcare Conferences
- Alphatec (ATEC) Misses Q3 EPS By 5c, Updates FY Outlook
- Alphatec Spine Announces Third Quarter 2008 Revenue and Financial Results
- Alphatec Spine Expands European Presence; Names Peter Kohlbecher as Vice President, General Manager - Europe
- Alphatec Spine Appoints Siri S. Marshall, Esq. to Its Board of Directors
More News related to New Coverage
- Friedman Billings Starts Aircastle (AYR) at Underperform
- Friedman Billings Starts Netflix (NFLX) at Market Perform
- Credit Suisse Starts 3PAR (PAR) at Neutral
- Credit Suisse Starts Netezza (NZ) at Neutral
- FBR Starts Amazon.com (AMZN) at Market Perform
Rodman & Renshaw initiates coverage on Alphatec Holdings (Nasdaq: ATEC) with a Market Perform rating.
Rodman analyst says, "A company in its 4th leg of transformation, with a newly formed management team focused on advancing its profile to now enter a $4.6 billion+ aging spine market, we believe current valuation largely reflects Alphatec s growth trajectory, with 1) a base business trending in line with market; and 2) an emerging business that is expected to register healthy growth, capped somewhat by a current lack of broader based clinical data and positive peer reviews."
Alphatec Holdings, Inc. is a medical technology company focused on the design, development, manufacturing and marketing of products for the surgical treatment of spine disorders.
Related Categories
New CoverageStocks Mentioned
+0.00Related Entities
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
